lasofoxifene has been researched along with Bone Loss, Osteoclastic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamilton, CJ; Jamal, SA; Swan, VJ | 1 |
Armamento-Villareal, R; Brodt, MD; Caruso, PL; Civelli, M; Civitelli, R; Galbiati, E; Halstead, LR; Mueller, C; Napoli, N; Nawaz, A; Sheikh, S; Silva, MJ | 1 |
Chidsey-Frink, KL; Crawford, DT; Ke, HZ; Qi, H; Thompson, DD | 1 |
1 review(s) available for lasofoxifene and Bone Loss, Osteoclastic
Article | Year |
---|---|
Lasofoxifene in osteoporosis and its place in therapy.
Topics: Bone Density; Bone Resorption; Breast Neoplasms; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Drug Approval; Europe; Female; Humans; Middle Aged; Musculoskeletal Diseases; Osteoporosis, Postmenopausal; Pyrrolidines; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Women's Health | 2010 |
2 other study(ies) available for lasofoxifene and Bone Loss, Osteoclastic
Article | Year |
---|---|
A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Topics: Absorptiometry, Photon; Amino Acids; Animals; Benzopyrans; Biomechanical Phenomena; Blood; Body Composition; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Cholesterol; Compressive Strength; Estrogen Receptor Modulators; Ethinyl Estradiol; Female; Femur; Femur Neck; Lumbar Vertebrae; Organ Size; Osteoclasts; Osteogenesis; Ovariectomy; Piperidines; Pyrrolidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Tibia; Tomography, X-Ray Computed; Triglycerides; Uterus; Weight-Bearing | 2005 |
Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
Topics: Adipose Tissue; Aging; Animals; Body Composition; Bone and Bones; Bone Density; Bone Resorption; Cholesterol; Drug Evaluation, Preclinical; Elasticity; Femur; Hypercholesterolemia; Lumbar Vertebrae; Male; Organ Size; Osteocalcin; Osteoclasts; Osteoporosis; Prostate; Pyrrolidines; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Stress, Mechanical; Tetrahydronaphthalenes; Tibia; Tomography, X-Ray Computed | 2001 |